These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


198 related items for PubMed ID: 229763

  • 1. Assessment of cellular immune response to cancer of the breast.
    Herberman RB.
    Ann Clin Lab Sci; 1979; 9(6):467-73. PubMed ID: 229763
    [Abstract] [Full Text] [Related]

  • 2. Detection of cell-mediated immune reactivity of breast cancer patients by the leukocyte adherence inhibition response to MCF-7 extracts.
    Rudczynski AB, Dyer CA, Mortensen RF.
    Cancer Res; 1978 Nov; 38(11 Pt 1):3590-4. PubMed ID: 81103
    [No Abstract] [Full Text] [Related]

  • 3. Cellular immunity to autologous breast cancer and RIII-murine mammary tumor virus preparations.
    Black MM, Zachrau RE, Shore B, Dion AS, Leis HP.
    Cancer Res; 1978 Jul; 38(7):2068-76. PubMed ID: 207421
    [No Abstract] [Full Text] [Related]

  • 4. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
    McCoy JL, Tagliabue A, Ames RE, Teramoto YA, Cannon GB, Alford C, Herberman RB, Schlom J.
    J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
    [Abstract] [Full Text] [Related]

  • 5. Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses.
    Fukuda M, Wanebo HJ, Tsuei L, Ashikari R, Sarkar NH.
    J Natl Cancer Inst; 1980 Mar; 64(3):431-7. PubMed ID: 6243720
    [Abstract] [Full Text] [Related]

  • 6. Antitumor immunity in breast cancer patients. Biologic and therapeutic implications.
    Black MM, Zachrau RE.
    J Reprod Med; 1979 Jul; 23(1):21-32. PubMed ID: 226697
    [Abstract] [Full Text] [Related]

  • 7. Specificity of the simultaneous cell-mediated immune reactivity to RIII murine mammary tumor virus glycoprotein 55 and human breast cancer tissues.
    Zachrau RE, Black MM, Dion AS, Shore B, Williams CJ, Leis HP.
    Cancer Res; 1978 Oct; 38(10):3414-20. PubMed ID: 80264
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cellular hypersensitivity of gp55 of RIII-murine mammary tumor virus and gp55-like protein of human breast cancers.
    Black MM, Zachrau RE, Dion AS, Shore B, Fine DL, Leis HP, Williams CJ.
    Cancer Res; 1976 Nov; 36(11 Pt 1):4137-42. PubMed ID: 184925
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunopathology of breast cancer.
    Black MM.
    Pathobiol Annu; 1977 Nov; 7():213-30. PubMed ID: 201905
    [No Abstract] [Full Text] [Related]

  • 12. Immunological studies in breast cancer. Modifying activity of the serum (MSA).
    Cervantes C, Muzio E, Exposito G, Garcia ME.
    Neoplasma; 1980 Nov; 27(4):379-86. PubMed ID: 7453855
    [Abstract] [Full Text] [Related]

  • 13. Leukocyte migration inhibition responses to MCF-7, murine mammary tumor virus, and Thomsen-Friedenreich antigen in a series of cancer patients.
    Bernhard MI, Wanebo HJ, Helm J, Pace RC, Kaiser DL.
    Cancer Res; 1983 Apr; 43(4):1932-7. PubMed ID: 6299532
    [No Abstract] [Full Text] [Related]

  • 14. Effect of murine milk samples and human breast tissues on human leukocyte migration indices.
    Black MM, Moore DH, Shore B, Zachrau RE, Leis H.
    Cancer Res; 1974 May; 34(5):1054-60. PubMed ID: 4363063
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
    Rentzsch C, Kayser S, Stumm S, Watermann I, Walter S, Stevanoviç S, Wallwiener D, Gückel B.
    Clin Cancer Res; 2003 Oct 01; 9(12):4376-86. PubMed ID: 14555509
    [Abstract] [Full Text] [Related]

  • 16. Cell-mediated immune responses of breast cancer patients to autologous tumor-associated antigens.
    Dean JH, McCoy JL, Cannon GB, Leonard CM, Perlin E, Kreutner A, Oldham RK, Herberman RB.
    J Natl Cancer Inst; 1977 Mar 01; 58(3):549-55. PubMed ID: 138751
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lymphoproliferative responses to mouse mammary tumor virus in lymphocyte subsets of breast cancer patients.
    Lopez DM, Parks WP, Silverman MA, Distasio JA.
    J Natl Cancer Inst; 1981 Aug 01; 67(2):353-8. PubMed ID: 6267344
    [Abstract] [Full Text] [Related]

  • 19. Peripheral leukocyte migration inhibition reactivity to breast cancer antigens in patients with breast cancer and in normal controls.
    Brandes LJ, Goldenberg GJ.
    Cancer Res; 1976 Oct 01; 36(10):3707-10. PubMed ID: 953996
    [Abstract] [Full Text] [Related]

  • 20. [Cellular antitumor immunity in an autologous system in stomach cancer].
    Kurtenkov OA.
    Vopr Onkol; 1981 Oct 01; 27(6):36-40. PubMed ID: 7269415
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.